Administration de la santé publique : Questions médicales fréquentes
Nom anglais: Public Health Administration
Descriptor UI:D011635
Tree Number:N04.452.794
Termes MeSH sélectionnés :
Natural Language Processing
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Administration de la santé publique : Questions médicales les plus fréquentes",
"headline": "Administration de la santé publique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Administration de la santé publique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-23",
"dateModified": "2025-02-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Administration de la santé publique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Organisation et administration",
"url": "https://questionsmedicales.fr/mesh/D009934",
"about": {
"@type": "MedicalCondition",
"name": "Organisation et administration",
"code": {
"@type": "MedicalCode",
"code": "D009934",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N04.452"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Administration de la santé publique",
"alternateName": "Public Health Administration",
"code": {
"@type": "MedicalCode",
"code": "D011635",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Stephen Thomson",
"url": "https://questionsmedicales.fr/author/Stephen%20Thomson",
"affiliation": {
"@type": "Organization",
"name": "ANU College of Law, The Australian National University, Canberra, Australia. stephen.thomson@anu.edu.au."
}
},
{
"@type": "Person",
"name": "Muhammad Zia Ud Din",
"url": "https://questionsmedicales.fr/author/Muhammad%20Zia%20Ud%20Din",
"affiliation": {
"@type": "Organization",
"name": "School of Public Administration, Central South University, Yuelu District, Changsha, Hunan, 410017, China."
}
},
{
"@type": "Person",
"name": "Xu Yuan Yuan",
"url": "https://questionsmedicales.fr/author/Xu%20Yuan%20Yuan",
"affiliation": {
"@type": "Organization",
"name": "School of Public Administration, Central South University, Yuelu District, Changsha, Hunan, 410017, China. xuyuanyuanj@163.com."
}
},
{
"@type": "Person",
"name": "Naqib Ullah Khan",
"url": "https://questionsmedicales.fr/author/Naqib%20Ullah%20Khan",
"affiliation": {
"@type": "Organization",
"name": "School of Public Administration, Central South University, Yuelu District, Changsha, Hunan, 410017, China. naqibkhan05@csu.edu.cn."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Identification and Characterization of Natural and Semisynthetic Quinones as Aurora Kinase Inhibitors.",
"datePublished": "2022-06-10",
"url": "https://questionsmedicales.fr/article/35687347",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.jnatprod.1c01222"
}
},
{
"@type": "ScholarlyArticle",
"name": "Theoretical Studies on the Structure and Intramolecular Interactions of Fagopyrins-Natural Photosensitizers of",
"datePublished": "2022-06-08",
"url": "https://questionsmedicales.fr/article/35744813",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/molecules27123689"
}
},
{
"@type": "ScholarlyArticle",
"name": "Natural killer cells and acute myeloid leukemia: promises and challenges.",
"datePublished": "2022-05-31",
"url": "https://questionsmedicales.fr/article/35639116",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00262-022-03217-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Neuroprotection in Acute Ischemic Stroke: A Battle Against the Biology of Nature.",
"datePublished": "2022-05-31",
"url": "https://questionsmedicales.fr/article/35711268",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fneur.2022.870141"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dynamic Modelling, Process Control, and Monitoring of Selected Biological and Advanced Oxidation Processes for Wastewater Treatment: A Review of Recent Developments.",
"datePublished": "2024-02-16",
"url": "https://questionsmedicales.fr/article/38391675",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/bioengineering11020189"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Administration des services de santé",
"item": "https://questionsmedicales.fr/mesh/D006298"
},
{
"@type": "ListItem",
"position": 3,
"name": "Organisation et administration",
"item": "https://questionsmedicales.fr/mesh/D009934"
},
{
"@type": "ListItem",
"position": 4,
"name": "Administration de la santé publique",
"item": "https://questionsmedicales.fr/mesh/D011635"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Administration de la santé publique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Administration de la santé publique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Administration de la santé publique",
"description": "Comment évaluer l'efficacité d'un programme de santé publique ?\nQuels outils sont utilisés pour le diagnostic en santé publique ?",
"url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Natural+Language+Processing&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Administration de la santé publique",
"description": "Quels symptômes indiquent un problème de santé publique ?\nComment les symptômes de maladies affectent-ils la santé publique ?",
"url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Natural+Language+Processing&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Administration de la santé publique",
"description": "Quelles stratégies de prévention sont efficaces ?\nComment la prévention est-elle mesurée ?",
"url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Natural+Language+Processing&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Administration de la santé publique",
"description": "Quels traitements sont prioritaires en santé publique ?\nComment les traitements sont-ils administrés en santé publique ?",
"url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Natural+Language+Processing&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Administration de la santé publique",
"description": "Quelles complications peuvent survenir sans intervention en santé publique ?\nComment les complications affectent-elles les systèmes de santé ?",
"url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Natural+Language+Processing&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Administration de la santé publique",
"description": "Quels sont les principaux facteurs de risque en santé publique ?\nComment identifier les facteurs de risque dans une population ?",
"url": "https://questionsmedicales.fr/mesh/D011635?mesh_terms=Natural+Language+Processing&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'efficacité d'un programme de santé publique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité se mesure par des indicateurs de santé, des enquêtes et des analyses de données."
}
},
{
"@type": "Question",
"name": "Quels outils sont utilisés pour le diagnostic en santé publique ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des enquêtes épidémiologiques, des statistiques de santé et des études de cohorte sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème de santé publique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des épidémies, des taux de mortalité élevés et des maladies infectieuses en hausse sont des indicateurs."
}
},
{
"@type": "Question",
"name": "Comment les symptômes de maladies affectent-ils la santé publique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils influencent les politiques de santé, la prévention et les ressources allouées aux soins."
}
},
{
"@type": "Question",
"name": "Quelles stratégies de prévention sont efficaces ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les campagnes de vaccination, l'éducation à la santé et les politiques de santé publique sont efficaces."
}
},
{
"@type": "Question",
"name": "Comment la prévention est-elle mesurée ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est mesurée par la réduction des cas de maladies, l'augmentation des vaccinations et des dépistages."
}
},
{
"@type": "Question",
"name": "Quels traitements sont prioritaires en santé publique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations, les traitements des maladies infectieuses et la santé maternelle sont prioritaires."
}
},
{
"@type": "Question",
"name": "Comment les traitements sont-ils administrés en santé publique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont souvent fournis par des programmes de santé communautaire et des campagnes de sensibilisation."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir sans intervention en santé publique ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des épidémies, des résistances aux antibiotiques et des maladies chroniques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles les systèmes de santé ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles augmentent la charge sur les systèmes de santé, nécessitant plus de ressources et de personnel."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque en santé publique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les comportements à risque, la pauvreté et l'accès limité aux soins sont des facteurs clés."
}
},
{
"@type": "Question",
"name": "Comment identifier les facteurs de risque dans une population ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Par des études épidémiologiques, des enquêtes et des analyses de données démographiques."
}
}
]
}
]
}
Aurora kinases (Aurora A, B, and C) are a family of serine/threonine kinases that play critical roles during mitotic initiation and progression. Aurora A and B kinases are ubiquitously expressed, and ...
Compounds characterized by a double-anthrone moiety are found in many plant species. One of them are fagopyrins-naturally occurring photosensitizers of...
Acute myeloid leukemia (AML) is considered as one of the most malignant conditions of the bone marrow. Over the past few decades, despite substantial progresses in the management of AML, relapse remis...
Stroke is the second most common cause of global death following coronary artery disease. Time is crucial in managing stroke to reduce the rapidly progressing insult of the ischemic penumbra and the s...
This review emphasizes the significance of formulating control strategies for biological and advanced oxidation process (AOP)-based wastewater treatment systems. The aim is to guarantee that the efflu...
In the pursuit of sustainability, managing agro-industrial and food processing residues (AFR) efficiently is crucial. This study proposes a systematic approach to convert AFR into valuable products vi...
Selective laser melting (SLM) of high-temperature alloys involves intricate interdependencies among key process parameters, such as laser power and scanning speed, affecting properties such as density...
The superheating process is a unique grain refining method found only in aluminum-containing magnesium alloys. It is a relatively simple method of controlling the temperature of the melt without addin...
In this review paper, the hot compressive deformation mechanisms and processing maps of high-entropy alloys (HEAs) with different chemical compositions and crystal structures are analyzed. The stress ...
The contribution of this work is introducing a multi-objective optimization method based on finite element (FE) numerical simulation to simultaneously control the curing time and cure-induced defects ...